NOTV Market Analysis

Overview

Fundamentals

P/E ratioForward 3.72
EPS (TTM)$-1.920.0% YoY
Profit margin-13.5%HEALTHCARE
Market cap$10.7MMicro cap

Valuation

Forward P/E
3.72
PEG ratio
P/B
0.10
P/S (TTM)
0.02
EV/EBITDA
19.92

Profitability & growth

ROE (TTM)
-49.8%
Operating margin
-13.4%
Revenue growth YoY
0.8%
Dividend yield
Beta
3.83
Last earnings
Feb 9, 2026 · Estimate $-0.51 · Reported $-0.83
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Inotiv Inc

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
2701 KENT AVENUE, WEST LAFAYETTE, IN
Fiscal year end
September
Latest quarter
Dec 31, 2025
Market cap$10.7M
Shares outstanding$34.4M
52W high$3.32
52W low$0.22

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer